CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 53 enrolled
Drug / intervention
Amoxicillin Clavulanate +1 moredrug
Likely dose
Amoxicillin Clavulanate 125 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01473368
NCT01473368N/ACompleted
CompareCT.gov

Open Label, Randomized Pilot Study to Examine The Effects of the Probiotic Saccharomyces Boulardii, the Antibiotic Amoxicillin/Clavulanate and the Combination on the Gut Microbiota of Healthy Volunteers

Beth Israel Deaconess Medical Center·interventional·Posted Nov 17, 2011·Updated Apr 4, 2017

In Brief

A clinical study evaluating Saccharomyces boulardii and Amoxicillin Clavulanate for Healthy Volunteers. Completed, enrolled 53 participants across 1 site.

Detailed Summary

The purpose of this study is to compare and contrast the effects of the probiotic Saccharomyces boulardii, the antibiotic amoxicillin/clavulanate and the combination on the gut microbiota of healthy volunteers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteers
CountriesUnited States
CollaboratorsBiocodex

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedNov 17, 2011
Enrollment StartApr 1, 2012
Primary CompletionFeb 1, 2013
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 14.6 years ago

Interventions

Saccharomyces boulardiidietary

500 mg, 2 times daily for 14 days

Amoxicillin Clavulanatedrug

875/125 mg 2 times daily at least 1 hour before meals for 7 days